Steve Maxson and William Cohn, MD

In this episode, Steve Maxson sits with Anant Hegde, CTO of Medeologix, to discuss his expertise in balloon tubing and complex extrusions.

Medeologix is a contract development and manufacturing partner for minimally invasive devices, they empower MedTech companies globally to transform visionary concepts into mass-produced realities. Their unparalleled engineering expertise and seamless design-for-manufacturing integration accelerate their clients’ product time to market, ensuring the swift delivery of innovative, high-quality medical devices that set new industry standards and ultimately enhance patient well-being. To learn more, go to www.medeologix.com.

Host/ Producer: Steve Maxson | Innovation & Business Development | US Extruders

Guest: Anant Hegde| CTO | Medeologix

Announcer: Bill Kramer | President | US Extruders

Editor/ Original Music: Eric Adair | Director of Communications & Digital Strategy| US Extruders

A new MedTech Unboxed episode is out now with Christopher Haig, President of Efemoral Medical, a company developing bioresorbable scaffolds for treating peripheral arterial disease (PAD), affecting over 200 million globally. Here’s a snapshot of our discussion:

• FlexStep Technology: A balloon-expandable, drug-eluting bioresorbable scaffold with inter-scaffold spaces for flexibility, made of PLLA with a co-polymer for ductility and rapid resorption (1-2 years), eluting sirolimus to prevent restenosis.

• Clinical Progress: The EFEMORAL I trial (33 patients enrolled across 4 sites in New Zealand/Australia) shows promise, with 20-patient results to be presented by Dr. Andrew Holden at @CXSymposium in London, April 23, 2025.

• Funding Update: Raised $10M+ in equity through angel investors and $2M+ in SBIR grants; targeting $20M Series B for IDE submission, including GLP animal studies and randomized trials for US PMA approval.